| 发明名称 |
ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY |
| 摘要 |
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions. |
| 申请公布号 |
US2016022630(A1) |
申请公布日期 |
2016.01.28 |
| 申请号 |
US201514878235 |
申请日期 |
2015.10.08 |
| 申请人 |
Vivus, Inc. |
发明人 |
Najarian Thomas;Tam Peter Y.;Wilson Leland F. |
| 分类号 |
A61K31/357;A61K31/137 |
主分类号 |
A61K31/357 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A controlled release composition for treating obesity, diabetes, sleep apnea, or a related condition in a subject comprising:
an effective amount of topiramate and phentermine. |
| 地址 |
Mountain View CA US |
